01—Abstract
Summary
Summary of the 10-K filed February 10, 2015. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group's 2014 10-K filing highlights a company with diversified operations across health benefits (UnitedHealthcare) and health services (Optum).
The report details significant revenue growth, driven by expansion in senior and public markets within UnitedHealthcare and strong performance across all Optum businesses, particularly OptumRx. Despite revenue growth, the company faced pressures from the Affordable Care Act (ACA) fees, Medicare Advantage funding reductions, and increased spending on specialty medications, which impacted earnings from operations for the UnitedHealthcare segment. Key financial highlights include a 7% increase in consolidated revenues to $130.5 billiona, with Optum revenues growing 25%.
Diluted earnings per share increased by 4% to $5.70b. The company also continued its focus on returning capital to shareholders through dividends and share repurchases, while managing its balance sheet with a debt-to-debt-plus-equity ratio of 34.9%. The filing also notes significant investments in technology and clinical capabilities, positioning the company for future growth in an evolving healthcare landscape.
02—Key points
Key Highlights
- Consolidated revenues grew 7% to $130.47 billion, with Optum segment revenues showing robust growth of 25%.
- UnitedHealthcare's revenue increased by 5%, driven by growth in public and senior markets, though operating earnings in this segment decreased by 2% due to ACA fees and Medicare Advantage funding reductions.
- Optum's businesses demonstrated strong performance, with OptumHealth up 12%, OptumInsight up 11%, and OptumRx up 33% in revenue.
- Diluted earnings per share increased by 4% to $5.70, although the company noted a negative year-over-year impact of approximately $1.00 per share from ACA fees and other ACA-related impacts.
- The company returned $5.4 billion to shareholders in 2014 through $4.0 billion in share repurchases and $1.4 billion in dividends.
- As of December 31, 2014, UnitedHealth Group served approximately 45 million individuals across its UnitedHealthcare medical businesses.
- The company had $8.6 billion in its order backlog for OptumInsight, indicating future revenue streams from technology and consulting services.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2014, UnitedHealth Group Inc kept $0.04.
- Revenue$130.47B100.0%
- Cost of revenue−$3.83B2.9%
- Gross profit$126.65B97.1%
- Operating costs−$116.37B89.2%
- Operating income$10.27B7.9%
- Interest, other & tax−$4.66B3.6%
- Net income$5.62B4.3%
Where FY2014 revenue went
$130.47B- Other operating costs: $95.11B, 73% of revenue
- SG&A: $21.26B, 16% of revenue
- Net income: $5.62B, 4.3% of revenue
- Cost of revenue: $3.83B, 2.9% of revenue
- Interest, other & tax: $4.66B, 3.6% of revenue
Kept 4.3% as net incomeNet income $5.62B · 4.3%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2014filed February 10, 2015Financial Statements
FY2014 against FY2013
| Line item | FY2014FY2013 | Change |
|---|---|---|
| Revenue | $130.47B$122.49B | +6.5% |
| Cost of Revenue | $3.83B$2.89B | +32.3% |
| Gross Profit | $126.65B$119.60B | +5.9% |
| SG&A Expenses | $21.26B$18.94B | +12.3% |
| Operating Expenses | $120.20B$112.87B | +6.5% |
| Operating Income | $10.27B$9.62B | +6.8% |
| Interest Expense | $618.00M$708.00M | −12.7% |
| Net Income | $5.62B$5.63B | −0.1% |
| EPS (Basic) | $5.78$5.59 | +3.4% |
| EPS (Diluted) | $5.70$5.50 | +3.6% |
| Shares Outstanding (Basic) | 972.00M1.01B | −3.4% |
| Shares Outstanding (Diluted) | 986.00M1.02B | −3.6% |
05—Questions
Frequently Asked Questions
What was the primary driver of revenue growth in 2014?
Consolidated revenues grew by 7% to $130.47 billion. This growth was primarily driven by an increase in the number of individuals served in the public and senior markets within UnitedHealthcare, and strong performance across all of Optum's businesses, particularly OptumRx.
What factors impacted UnitedHealthcare's earnings from operations in 2014?
UnitedHealthcare's operating earnings decreased by 2% compared to the prior year. This was primarily due to the introduction of ACA fees, Medicare Advantage funding reductions, increased spending on specialty medications (like those for Hepatitis C), and reduced levels of favorable medical cost reserve development. These factors were partially offset by growth in public and senior markets, reduced inpatient hospital utilization, and revenue true-ups.
How did the Affordable Care Act (ACA) impact the company's financial results?
The ACA had a mixed impact. While it drove membership growth in certain markets (like Medicaid expansion), the associated ACA Fees negatively impacted the medical care ratio and operating cost ratio. The company noted that these fees reduced diluted EPS by approximately $1.00 year-over-year. Medicare Advantage rates were also affected by ACA-related changes and sequestration cuts.
What is the significance of the Optum segment to UnitedHealth Group's overall business?
The Optum segment, comprising OptumHealth, OptumInsight, and OptumRx, is a key growth driver. In 2014, Optum revenues grew by 25%, contributing significantly to the company's overall performance. OptumRx, in particular, saw a 33% revenue increase due to expanded services for both UnitedHealthcare members and external clients.
06—Continue